Get a glimpse into our company and investor data—powered by the PitchBook Platform
AngelLATEST DEAL TYPE
$4.5MLATEST DEAL AMOUNT
Owner and operator of a bio pharmaceutical company. The company offers therapeutic and diagnostic products and services for Acute Ischaemic Stroke (AIS) and potentially other life-threatening and serious conditions.